Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy

Autor: Munekane, Asami, Ohsawa, Yutaka, Okubo, Mariko, Nagai, Taiji, Nishimura, Hirotake, Nishino, Ichizo, Sunada, Yoshihide

Publikováno v: Internal Medicine
Internal Medicine, 2022, pp.0202-22. ⟨10.2169/internalmedicine.0202-22⟩

Becker muscular dystrophy (BMD) is an X-linked neuromuscular disease characterized by progressive muscle weakness that currently has no cure. Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune inflammatory myopathy characterized by p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed55c89777276b1a10709dd00849a818
https://pubmed.ncbi.nlm.nih.gov/36130887

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.

Autor: Munekane A; Department of Neurology, Kawasaki Medical School, Japan., Ohsawa Y; Department of Neurology, Kawasaki Medical School, Japan., Okubo M; Department of Neuromuscular Research, National Institute of Neuroscience (NCNP), Japan., Nagai T; Department of Neurology, Kawasaki Medical School, Japan., Nishimura H; Department of Pathology, Kawasaki Medical School, Japan., Nishino I; Department of Neuromuscular Research, National Institute of Neuroscience (NCNP), Japan., Sunada Y; Department of Neurology, Kawasaki Medical School, Japan.

Publikováno v: Internal medicine (Tokyo, Japan) [Intern Med] 2023 May 01; Vol. 62 (9), pp. 1345-1349. Date of Electronic Publication: 2022 Sep 21.